Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Singulair montelukast: Phase III data; marketed to treat asthma

MRK said that pooled data from 1,445 patients in 3

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE